Collectively, we revealed that FTO drives lung cancer progression via m6A‐dependent sequestration of IGFBP3 mRNA into P‐bodies by IMP3, which suppresses translation and activates AKT signalling. The gene discussed is FTO; the disease is lung carcinoma.